Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, April 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 5 publications that cite this research output.

5

The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.

Serum Creatinine/Cystatin C Ratio in Chronic Obstructive Pulmonary Disease Patients and its Corelation to Disease Severity

Article in Benha Medical Journal (May 2024)

The creatinine-to-cystatin C ratio (a surrogate marker of muscle mass) as a predictor of lung function decline in older adults: A nationwide longitudinal study in China

Article in Respiratory Medicine (March 2023)

Serum creatinine/cystatin C ratio as a muscle mass evaluating tool and prognostic indicator for hospitalized patients: A meta-analysis

Article in Frontiers in Medicine (January 2023)